Sustainability|

SHL Medical releases the 2023 sustainability report

Shl Medical Sustainability Report 2023
SHL Medical’s sustainability report provides a comprehensive overview of the company’s progress towards its sustainability goals

SHL Medical is pleased to announce the release of its 2023 sustainability report, which details the company’s ongoing efforts and accomplishments in sustainability and innovation. The publication of this report marks another milestone in the company’s journey towards transparency, accountability, and continuous improvement.

“Sustainability remains an integral part of our corporate strategy,” said Ulrich Faessler, CEO of SHL Medical. “The 2023 sustainability report highlights not only our progress and achievements but also reaffirms our commitment to making positive social and environmental impact while advancing the development of innovative self-injection solutions.”

The report emphasizes the company’s goals, initiatives, and progress towards three sustainability goals it has set:

Driving patient health and independence

SHL Medical is committed to enabling 8 million patients’ independence by 2030. To date, the company has successfully supported 3.1 million patients with its innovative self-injection solutions.

Reducing ecological footprint

SHL Medical seeks to drive circularity across our products and operations by reducing our greenhouse gas emissions, transitioning to renewable electricity, as well as reducing and recycling waste.

The sustainability report further outlines the company’s progresses against the targets it set throughout 2023:

  • 6% reduction of our greenhouse gas emissions compared to 2022
  • 100% renewable electricity in Europa and US
  • 12% increase of renewable electricity shared globally compared to 2022
  • 74% of waste recycled and less than 1% of landfilled waste

Thanks to its efforts, SHL Medical is rewarded with:

Ensuring responsible business practices across supply chain, employees, and its communities

SHL Medical continuously strives to empower its employees and endorse ethical business practices by:

  • Enhancing workplace safety
  • Providing relevant trainings to its employees
  • Creating a diverse, equal, and inclusive environment
  • Ensuring responsible business practices across operations and supply chain

As part of the commitment, SHL Medical becomes a member and signatory of United Nations Global Compact (UNGC) and its Ten Principles in 2023.

“We believe that embedding sustainability in our business model is essential for our long-term business success,” said Dora Rio, Global Head of Sustainability at SHL Medical. “By adhering to our core values, an ambitious sustainability agenda, tangible actions, and collective effort, we are committed to working towards a future where healthcare solutions are not only of high quality, effective, and safe, but also environmentally and socially responsible.”

By embracing innovative mindset, collaborative spirit, and responsible practices, SHL Medical strives to lead by example in driving positive changes and shaping a more sustainable world for future generations.

 

 

For more information about SHL Medical’s sustainability strategies, please visit https://www.shl-medical.com/sustainability.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.